CAS: 2411440-41-8
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | (S)-2-(5-(Bis(4-chlorophenyl)methyl)-3-methylthiophene-2-carboxamido)-5-guanidinopentanoic acid REF: IN-DA0201XECAS: 2411440-41-8 | 95% | A consultar | Mar 10 Dic 24 |
 | JR14a REF: TM-T9316CAS: 2411440-41-8 | 99.29% | 90,00 €~1.003,00 € | Vie 13 Dic 24 |
 | JR14a REF: 3D-LWD44041CAS: 2411440-41-8 | Min. 95% | A consultar | Vie 17 Ene 25 |
(S)-2-(5-(Bis(4-chlorophenyl)methyl)-3-methylthiophene-2-carboxamido)-5-guanidinopentanoic acid
CAS:2411440-41-8
Fórmula:
C25H26Cl2N4O3S
Pureza:
95%
Peso molecular:
533.4699
Ref: IN-DA0201XE
| 5mg | 138,00 € | ||
| 10mg | 152,00 € | ||
| 25mg | 300,00 € | ||
| 50mg | 637,00 € | ||
| 100mg | A consultar | ||
| 250mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
JR14a
CAS:2411440-41-8
JR14a (5-(Bis(4-chlorophenyl)methyl)-3-methylthiophene-2-carbonyl)-l-arginine hydrochloride) is a potent antagonist of human complement C3a receptor.
Fórmula:
C25H26Cl2N4O3S
Pureza:
99.29%
Forma y color:
Solid
Peso molecular:
533.47
Ref: TM-T9316
| 1mg | 90,00 € | ||
| 5mg | 184,00 € | ||
| 10mg | 292,00 € | ||
| 25mg | 495,00 € | ||
| 50mg | 714,00 € | ||
| 100mg | 1.003,00 € | ||
| 1mL*10mM (DMSO) | 214,00 € |
Entrega estimada en Estados Unidos, el Viernes 13 de Diciembre de 2024
JR14a
CAS:2411440-41-8
JR14a is an analog inhibitor of protein kinases, which has shown promising results in the …
Fórmula:
C25H26Cl2N4O3S
Pureza:
Min. 95%
Peso molecular:
533.5 g/mol
Ref: 3D-LWD44041
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 17 de Enero de 2025
